A new treatment strategy for thrombotic thrombocytopenic purpura in developing countries: A single dose rituximab-contained regimen

Thromb Res. 2022 Dec:220:72-74. doi: 10.1016/j.thromres.2022.10.002. Epub 2022 Oct 7.
No abstract available

Keywords: Microangiopathic hemolytic anemia; Plasma exchange; Rituximab; Thrombotic thrombocytopenic purpura.

Publication types

  • Letter

MeSH terms

  • ADAMTS13 Protein
  • Developing Countries
  • Female
  • Humans
  • Plasma Exchange
  • Pregnancy
  • Pregnancy Complications, Hematologic* / drug therapy
  • Purpura, Thrombotic Thrombocytopenic* / drug therapy
  • Rituximab / therapeutic use

Substances

  • Rituximab
  • ADAMTS13 Protein